Application of an Accessible Interface for Pharmacokinetic Modeling and In Vitro to In Vivo Extrapolation

15Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Regulatory toxicology testing has traditionally relied on in vivo methods to inform decision-making. However, scientific, practical, and ethical considerations have led to an increased interest in the use of in vitro and in silico methods to fill data gaps. While in vitro experiments have the advantage of rapid application across large chemical sets, interpretation of data coming from these non-animal methods can be challenging due to the mechanistic nature of many assays. In vitro to in vivo extrapolation (IVIVE) has emerged as a computational tool to help facilitate this task. Specifically, IVIVE uses physiologically based pharmacokinetic (PBPK) models to estimate tissue-level chemical concentrations based on various dosing parameters. This approach is used to estimate the administered dose needed to achieve in vitro bioactivity concentrations within the body. IVIVE results can be useful to inform on metrics such as margin of exposure or to prioritize potential chemicals of concern, but the PBPK models used in this approach have extensive data requirements. Thus, access to input parameters, as well as the technical requirements of applying and interpreting models, has limited the use of IVIVE as a routine part of in vitro testing. As interest in using non-animal methods for regulatory and research contexts continues to grow, our perspective is that access to computational support tools for PBPK modeling and IVIVE will be essential for facilitating broader application and acceptance of these techniques, as well as for encouraging the most scientifically sound interpretation of in vitro results. We highlight recent developments in two open-access computational support tools for PBPK modeling and IVIVE accessible via the Integrated Chemical Environment (https://ice.ntp.niehs.nih.gov/), demonstrate the types of insights these tools can provide, and discuss how these analyses may inform in vitro-based decision making.

References Powered by Scopus

Adverse outcome pathway (AOP) development I: Strategies and principles

557Citations
N/AReaders
Get full text

Improving the human hazard characterization of chemicals: A Tox21 update

541Citations
N/AReaders
Get full text

Key characteristics of carcinogens as a basis for organizing data on mechanisms of carcinogenesis

508Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Artificial intelligence (AI)—it’s the end of the tox as we know it (and I feel fine)*

24Citations
N/AReaders
Get full text

In-Depth Analysis of Physiologically Based Pharmacokinetic (PBPK) Modeling Utilization in Different Application Fields Using Text Mining Tools

8Citations
N/AReaders
Get full text

Key challenges for in vitro testing of tobacco products for regulatory applications: Recommendations for dosimetry

6Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Hines, D. E., Bell, S., Chang, X., Mansouri, K., Allen, D., & Kleinstreuer, N. (2022). Application of an Accessible Interface for Pharmacokinetic Modeling and In Vitro to In Vivo Extrapolation. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.864742

Readers' Seniority

Tooltip

Researcher 5

71%

Professor / Associate Prof. 1

14%

PhD / Post grad / Masters / Doc 1

14%

Readers' Discipline

Tooltip

Pharmacology, Toxicology and Pharmaceut... 4

57%

Social Sciences 2

29%

Agricultural and Biological Sciences 1

14%

Save time finding and organizing research with Mendeley

Sign up for free